US EditionAnbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
METRO MANILA, PHILIPPINES, AUG 09 – Anbio Biotechnology introduces rapid tests enhancing detection of Chikungunya and other pathogens, with a 15-minute PCR system improving outbreak response and healthcare capacity globally.
- Anbio Biotechnology launched its Chikungunya IgM/IgG Rapid Test and AP-100 Ultra-Fast PCR system on 2025-08-09 to enhance infectious disease diagnostics.
- The launch responds to rising Chikungunya cases in tropical regions and the need for faster, decentralized molecular diagnostic tools.
- The rapid test uses immunochromatographic technology for reliable antibody detection in serum, plasma, or whole blood, while the AP-100 delivers 15-minute extraction-free PCR results.
- Michael Lau, CEO of Anbio, stated that the AP-100 significantly shortens the turnaround time of traditional PCR tests from several hours to just minutes, while maintaining the same level of accuracy, enabling quicker responses to disease outbreaks.
- Anbio’s expanded portfolio, including planned TB and HPV tests, aims to strengthen healthcare capacity and improve global infectious disease management.
Insights by Ground AI
Does this summary seem wrong?
92 Articles
92 Articles
Rutland Herald+88 Reposted by 88 other sources
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide.
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - Anbio Biotechnology (NASDAQ:NNNN)
FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE) -- In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible diagnostic tool at the point of care. As cases continue to rise across tropical and subtropical regions, timely detection and differentiation from other arboviral infections like Dengue an…
·New York, United States
Read Full Article
Coverage Details
Total News Sources92
Leaning Left11Leaning Right8Center29Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 23%
C 60%
R 17%
Factuality
To view factuality data please Upgrade to Premium
